Technology
Health
Pharmaceutical

Liquidia Technologies

$7.61
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.24 (-3.01%) As of 1:58 PM EDT today
-$0.24 (-3.01%) Today

Why Robinhood?

You can buy or sell LQDA and other stocks, options, ETFs, and crypto commission-free!

About LQDA

Liquidia Technologies, Inc. Common Stock, also called Liquidia Technologies, is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. Read More It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.

Employees
63
Headquarters
Morrisville, North Carolina
Founded
2004
Market Cap
146.30M
Price-Earnings Ratio
Dividend Yield
Average Volume
82.19K
High Today
$8.03
Low Today
$7.48
Open Price
$7.80
Volume
66.58K
52 Week High
$38.46
52 Week Low
$7.21

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Therapy
2018 IPO
US

LQDA Earnings

-$0.87
-$0.77
-$0.67
-$0.57
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 1, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.